Top Stories
-
Twenty years ago, Columbia scientists created a way to make neurons in a dish, a discovery that has led to clinical trials of an experimental drug that may slow the progression of ALS.
Topic
-
Using EEG to identify covert consciousness in unresponsive brain-injured patients could help predict which ones may recover, find researchers at Columbia and NewYork-Presbyterian.
Topic
-
Research from Scott Small's lab at Columbia University suggests a different approach to tackling the disease, and a new startup company is now trying to turn that approach into treatments.
Topic
-
A gene called FMNL2 may explain why people with hypertension, diabetes, heart disease, or obesity have a greater risk of developing Alzheimer's disease.
Topic
Latest News
- August 9, 2013
Watch all eight talks from TEDMED Day CUMC, now available online.
Topic
- July 24, 2013
Key molecular pathways that lead to Alzheimer's identified—a new approach to Alzheimer’s research; several potential drug targets highlighted.
Topic
- July 11, 2013
In an article in Scientific American’s “Talking Back Blog” published yesterday, writer Gary Stix highlights the work of Columbia’s Dr. Olajide Williams.
Topic
- June 27, 2013
Ottavio Arancio, MD, PhD, of CUMC's Taub Institute, coauthored a paper on a compound that prevents memory loss in a mouse model of Alzheimer's. See Northwestern's news release: http://bit.ly/14Zqwwn
Topic
- June 25, 2013
Mouse study suggests inhibiting protein called caspase-2 might prevent cognitive decline in Alzheimer's
Topic
- June 19, 2013
One in 4 stroke survivors suffer from PTSD symptoms within the 1st year post-event, and 1 in 9 experience chronic PTSD more than a year later - results of a study led by Columbia University Medical Center researchers.
Topic
- May 6, 2013
Columbia University study looks at the relationship between families with exceptional longevity and cognitive impairment consistent with Alzheimer's disease.
Topic
- May 1, 2013
Four research centers including the Center for Stroke Disparities Solutions—a partnership of the New York University Langone Medical Center and Columbia University Medical Center —will develop high-impact culturally tailored interventions aimed at lowering stroke risk among racial and ethnic minorities in the United States.
Topic
- April 17, 2013
Excess glutamate in the brain may spur psychosis in those at risk for schizophrenia, report CUMC investigators in a study published in Neuron.
Topic
-
Source:
Alzheimer Research ForumApril 10, 2013African-Americans carrying a variant in a cholesterol-processing gene, ABCA7, have double the risk for Alzheimer’s than non-carriers. A new study led by CUMC's Richard Mayeux; first author Christiane Reitz.
Topic
